FIELD: chemistry.
SUBSTANCE: invention relates to formula compound or to its pharmaceutically acceptable salt, where R represents COOH or CH2OH. Invention also relates to pharmaceutical composition based on formula I, method of modulating CFTR activity in biological sample, based on application of formula I compound, method of treatment, based on application of formula I compound, set based on formula I compound.
EFFECT: obtained are novel derivatives of quinolin-4-one, useful as CFTR modulators.
18 cl, 1 tbl, 8 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD OF OBTAINING MODULATORS OF CYSTIC FIBROUSIS TRANSMEMBRANE CONDUCTANCE REGULATOR | 2010 |
|
RU2543714C2 |
METHOD FOR OBTAINING MODULATORS OF CYSTIC FIBROUSIS TRANSMEMBRANE CONDUCTANCE REGULATOR | 2010 |
|
RU2553989C2 |
SILICON-CONTAINING IVACAFTOR ANALOGUES | 2017 |
|
RU2796112C2 |
METHOD OF PRODUCING CYCLOALKYLCARBOXAMIDO-INDOLE COMPOUNDS | 2011 |
|
RU2745977C2 |
METHOD FOR PRODUCING CYCLOALKYLCARBOXAMIDO-INDOLE COMPOUNDS | 2011 |
|
RU2569678C2 |
METHOD OF PRODUCING PHARMACEUTICAL COMPOSITIONS FOR TREATING CFTR MEDIATED DISEASES | 2014 |
|
RU2718044C2 |
PHARMACEUTICAL COMPOSITIONS FOR TREATING DISEASES MEDIATED BY A TRANSMEMBRANE REGULATOR OF CYSTIC FIBROSIS (CFTR) | 2013 |
|
RU2692676C2 |
SOLID FORMS OF (R)-1-(2,2-DIFLUOROBENZO[d][1,3]DIOXOL-5-YL)-N-(2,3-DIHYDROXYPROPYL)-6-FLUORO-2-(1-HYDROXY-2-METHYLPROPAN-2-YL)-1H-INDOL-5-YL)CYCLOPROPANE CARBOXAMIDE | 2011 |
|
RU2573830C2 |
SOLID FORMS OF (R)-1-(2, 2-DIFLUOROBENZO[D][1, 3]DIOXOL-5-YL)-N-(1-(2,3-DIHYDROXYPROPYL)-6-FLUORO-2-(1-HYDROXY-2-METHYLPROPAN-2-YL)-1H-INDOL-5-YL) CYCLOPROPANECARBOXAMIDE | 2011 |
|
RU2711481C2 |
NEW TREATMENT | 2015 |
|
RU2688191C2 |
Authors
Dates
2014-06-10—Published
2010-03-19—Filed